文献速递腹部技术与安全CT

利用全自动腹部CT生物标志物对无症状成人代谢综合征进行机会性筛查

Utilizing Fully Automated Abdominal CT-Based Biomarkers for Opportunistic Screening for Metabolic Syndrome in Adults Without Symptoms.
PubMed 文献 · AJR Am J Roentgenol · 2020-11-10

本研究对7785例无症状成人行平扫腹部CT,应用全自动算法定量肌肉、内脏及皮下脂肪、肝脂肪和腹主动脉钙化,按国际糖尿病联盟标准诊断代谢综合征。738例(9.5%)符合标准,L1层面总腹部脂肪阈值460.6 cm²诊断敏感度80.1%、特异度85.4%,联合脂肪与肌肉指标在女性中AUROC达0.930。

要点

  • L1层面总腹部脂肪是代谢综合征最强的CT生物标志物,AUROC为0.909。
  • L1层面总腹部脂肪阈值460.6 cm²,敏感度80.1%、特异度85.4%。
  • 女性联合脂肪与肌肉指标AUROC达0.930,优于单一指标。

核心结论

  • 腹部CT全自动定量脂肪、肌肉和肝脏组织指标有助于识别代谢综合征风险个体。
  • 这些内脏指标可机会性应用于因其他临床指征所做的CT扫描,并可能最终提供更直接有用的代谢综合征定义。

研究设计与样本

  • 研究纳入9223例无症状成人行平扫腹部CT,排除临床数据不足以诊断者后最终队列为7785例(平均年龄57.0岁;4361名女性、3424名男性)。
  • 采用国际糖尿病联盟标准诊断代谢综合征,并应用既往验证的全自动CT算法定量肌肉、内脏及皮下脂肪、肝脂肪和腹主动脉钙化。

关键影像表现/征象

  • 代谢综合征组后续主要心血管事件发生更频繁(p < 0.001)。
  • 两组间所有CT生物标志物均存在显著差异(p < 0.001)。

诊断标准与关键数值

  • L1层面总腹部脂肪单变量AUROC为0.909,OR为27.2。
  • L3层面骨骼肌指数AUROC为0.776,OR为5.8。
  • 容积肝脏衰减AUROC为0.738,OR为5.1。
  • 腹主动脉钙化评分AUROC为0.578,OR为1.6。
  • L1层面总腹部脂肪阈值460.6 cm²诊断代谢综合征敏感度80.1%、特异度85.4%;女性联合脂肪与肌肉指标AUROC为0.930。

临床应用与阅片要点

  • 对因其他临床指征行腹部CT的无症状成人,可机会性应用全自动定量脂肪、肌肉和肝脏指标识别代谢综合征风险个体。
  • L1层面总腹部脂肪阈值460.6 cm²可作为代谢综合征机会性筛查的参考指标。
  • 女性可联合脂肪与肌肉指标提高识别效能(AUROC 0.930)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Metabolic syndrome describes a constellation of reversible cardiometabolic abnormalities associated with cardiovascular risk and diabetes. The present study investigates the use of fully automated abdominal CT-based biometric measures for opportunistic identification of metabolic syndrome in adults without symptoms.

MATERIALS AND METHODS: International Diabetes Federation criteria were applied to a cohort of 9223 adults without symptoms who underwent unenhanced abdominal CT. After patients with insufficient clinical data for diagnosis were excluded, the final cohort consisted of 7785 adults (mean age, 57.0 years; 4361 women and 3424 men). Previously validated and fully automated CT-based algorithms for quantifying muscle, visceral and subcutaneous fat, liver fat, and abdominal aortic calcification were applied to this final cohort.

RESULTS: A total of 738 subjects (9.5% of all subjects; mean age, 56.7 years; 372 women and 366 men) met the clinical criteria for metabolic syndrome. Subsequent major cardiovascular events occurred more frequently in the cohort with metabolic syndrome (p < 0.001). Significant differences were observed between the two groups for all CT-based biomarkers (p < 0.001). Univariate L1-level total abdominal fat (area under the ROC curve [AUROC] = 0.909; odds ratio [OR] = 27.2), L3-level skeletal muscle index (AUROC = 0.776; OR = 5.8), and volumetric liver attenuation (AUROC = 0.738; OR = 5.1) performed well when compared with abdominal aortic calcification scoring (AUROC = 0.578; OR = 1.6). An L1-level total abdominal fat threshold of 460.6 cm2 was 80.1% sensitive and 85.4% specific for metabolic syndrome. For women, the AUROC was 0.930 when fat and muscle measures were combined.

CONCLUSION: Fully automated quantitative tissue measures of fat, muscle, and liver derived from abdominal CT scans can help identify individuals who are at risk for metabolic syndrome. These visceral measures can be opportunistically applied to CT scans obtained for other clinical indications, and they may ultimately provide a more direct and useful definition of metabolic syndrome.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Pickhardt PJ, Graffy PM, Zea R, et al. Utilizing Fully Automated Abdominal CT-Based Biomarkers for Opportunistic Screening for Metabolic Syndrome in Adults Without Symptoms. AJR Am J Roentgenol. 2020. PMID: 32603223. doi:10.2214/AJR.20.23049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。